Intestinal cancer
MONDO:0005814A malignant neoplasm involving the intestine
Also known as: bowel cancer, cancer of intestine, cancer of the intestine, intestinal cancer, intestinal neoplasms, malignant, intestinal tumors, malignant, intestine cancer, malignant intestinal neoplasm
5451 clinical trials for this condition and its sub-types, 25 tagged with Intestinal cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Intestinal cancer
-
Colorectal cancer 1,767 trials · 2,697 incl. sub-types
5 sub-types
- Colorectal carcinoma 305 trials · 1,166 incl. sub-types Sub-types →
- Rectal cancer 433 trials · 633 incl. sub-types Sub-types →
- Malignant colon neoplasm 62 trials · 437 incl. sub-types Sub-types →
- Familial colorectal cancer 3 trials · 91 incl. sub-types Sub-types →
- Colorectal lymphoma 0 trials Sub-types →
-
Small intestine cancer 8 trials · 118 incl. sub-types
6 sub-types
- Small intestine carcinoma 19 trials · 105 incl. sub-types Sub-types →
- Duodenum cancer 15 trials · 82 incl. sub-types Sub-types →
- Small intestine lymphoma 3 trials Sub-types →
- Small intestinal sarcoma 0 trials · 1 incl. sub-types Sub-types →
- Ileum cancer 0 trials Sub-types →
- Jejunal cancer 0 trials Sub-types →
-
Anal canal cancer 22 trials · 44 incl. sub-types
1 sub-type
- Anal canal carcinoma 4 trials · 34 incl. sub-types Sub-types →
-
Intestine carcinoma in situ 0 trials · 16 incl. sub-types
2 sub-types
- Rectum carcinoma in situ 1 trial · 13 incl. sub-types Sub-types →
- Colon carcinoma in situ 3 trials Sub-types →
-
Colorectal Kaposi sarcoma 0 trials
2 sub-types
- Colon Kaposi sarcoma 0 trials
- Rectum Kaposi sarcoma 0 trials
Most studied deeper sub-types
-
New drug cocktail shows promise for Hard-to-Treat colorectal cancer
Disease control OngoingThis study tests whether a combination of two targeted drugs (encorafenib and cetuximab), given alone or with chemotherapy, works better than standard chemotherapy for people with a specific genetic form of advanced colorectal cancer (BRAF V600E mutation) that has spread and hasn…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New pill targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called RMC-6291 in adults with advanced cancers (lung, colon, pancreatic) that have a specific KRAS G12C mutation. The goal is to find the safest dose and see how well the drug works. About 222 participants will receive the drug by mouth, a…
Phase 1 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug combo takes on advanced cancers in early trial
Disease control OngoingThis early-stage trial is testing a new drug called KFA115, either by itself or combined with the immunotherapy Keytruda (pembrolizumab), in 126 people with advanced cancers like lung, skin, kidney, and others. The main goal is to check safety and find the best dose. It is not ye…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Frailty check could predict chemo danger for seniors
Knowledge-focused By invitation onlyThis study looks at how frailty—a state of weakness and reduced physical function—affects the risk of severe side effects from chemotherapy in people aged 70 and older with cancer. Researchers will assess 160 patients using various tests for frailty, muscle loss, and overall heal…
Sponsor: Azienda Socio Sanitaria Territoriale Ovest Milanese, Ospedale di Legnano • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC